Melatonin Replacement Therapy in Pinealectomized Patients
Condition(s):Pineal TumorLast Updated:March 21, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Pineal TumorLast Updated:March 21, 2019Completed
Condition(s):Brain TumorLast Updated:March 23, 2023Not yet recruiting
Condition(s):Brain Stem Neoplasms; Glioma; PinealomaLast Updated:July 2, 2017Withdrawn
Condition(s):PineoblastomaLast Updated:August 5, 2021Completed
Condition(s):Ependymomas; Gliomas; PNET; Pineal Tumors; PCNSL (Primary CNS Lymphoma)Last Updated:December 3, 2019Terminated
Condition(s):Retinoblastoma; PineoblastomaLast Updated:December 29, 2015Completed
Condition(s):Brain Tumor; Medulloblastoma; PineoblastomaLast Updated:January 9, 2023Active, not recruiting
Condition(s):Brain and Central Nervous System TumorsLast Updated:August 2, 2013Completed
Condition(s):Glioma; Glioneuronal Tumor; Choroid Plexus Tumor; Pineal Tumors; Germ Cell Tumor; Tumor of the Sellar Region; Diffuse Midline Glioma, H3 K27M-Mutant; Ependymoma; Embryonal Tumor; Pineal Tumor; Hemangiopericytoma; Hemangioblastoma; Melanocytic Tumor of CNSLast Updated:March 30, 2023Recruiting
Condition(s):Anaplastic Astrocytoma; Anaplastic Ependymoma; Anaplastic Ganglioglioma; Anaplastic Meningioma; Anaplastic Oligodendroglioma; Pleomorphic Xanthoastrocytoma, Anaplastic; Atypical Teratoid/Rhabdoid Tumor; Brain Cancer; Brain Tumor; Central Nervous System Neoplasms; Choroid Plexus Carcinoma; CNS Embryonal Tumor With Rhabdoid Features; Ganglioneuroblastoma of Central Nervous System; CNS Tumor; Embryonal Tumor of CNS; Ependymoma; Glioblastoma; Glioma; Glioma, Malignant; Medulloblastoma; Medulloblastoma; Unspecified Site; Medulloepithelioma; Neuroepithelial Tumor; Neoplasms; Neoplasms, Neuroepithelial; Papillary Tumor of the Pineal Region (High-grade Only); Pediatric Brain Tumor; Pineal Parenchymal Tumor of Intermediate Differentiation (High-grade Only); Pineoblastoma; Primitive Neuroectodermal Tumor; Recurrent Medulloblastoma; Refractory Brain Tumor; Neuroblastoma. CNS; Glioblastoma, IDH-mutant; Glioblastoma, IDH-wildtype; Medulloblastoma, Group 3; Medulloblastoma, Group 4; Glioma, High Grade; Neuroepithelial Tumor, High Grade; Medulloblastoma, SHH-activated and TP53 Mutant; Medulloblastoma, SHH-activated and TP53 Wildtype; Medulloblastoma, Chromosome 9q Loss; Medulloblastoma, Non-WNT Non-SHH, NOS; Medulloblastoma, Non-WNT/Non-SHH; Medulloblastoma, PTCH1 Mutation; Medulloblastoma, WNT-activated; Ependymoma, Recurrent; Glioma, Recurrent High Grade; Glioma, Recurrent Malignant; Embryonal Tumor, NOS; Glioma, Diffuse Midline, H3K27M-mutant; Embryonal Tumor With Multilayered Rosettes (ETMR); Ependymoma, NOS, WHO Grade III; Ependymoma, NOS, WHO Grade II; Medulloblastoma, G3/G4; Ependymoma, RELA Fusion PositiveLast Updated:March 21, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.